Camille L. Bedrosian, M.D.

Camille L. Bedrosian, M.D.

Chief Medical OfficeratAmylyx Pharmaceuticals· In proxies 2023–2025

Pay in FY2025Amylyx Pharmaceuticals stock +219.6% the same year

Camille L. Bedrosian, M.D. was paid $1.6M in FY2025 (Dec). Amylyx Pharmaceuticals stock rose 219.6% that year.

Pay$100 in the stock at the end of FY22 → $127
Pay is from the Summary Compensation Table of each Amylyx Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Amylyx PharmaceuticalsPublic company · 3 yr
    • Chief Medical Officer2023 – Present · 3 yrStock in role -19%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?